Retrospective Analysis of the Utility Formal Psychosocial Support in Enhancing the Outcome of Pregnancies in Opiate-addicted Pregnant Women in Agonist Maintenance Programs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 113
- Locations
- 1
- Primary Endpoint
- Percentage of newborns in each group that required pharmacological treatment for neonatal abstinence syndrome
Study Overview
Brief Summary
Opiate drug abuse/addiction is a significant co-morbidity in pregnancy. Opiate maintenance program enhances the outcome of pregnancies for the mother and the infant. Our objective was to assess if provision of structured psychosocial support in addition to methadone maintenance program adds incremental benefits with regards to the outcome of pregnancy.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Positive Methadone tox screen
- •Received care at Good Samaritan Hospital in Cincinnati
- •Delivered at Good Samaritan Hospital
Exclusion Criteria
- •Twin gestation
- •Sever congenital anomalies
- •Conditions requiring transfer to quaternary hospital
Outcomes
Primary Outcomes
Percentage of newborns in each group that required pharmacological treatment for neonatal abstinence syndrome
Time Frame: Birth until discharge
Infants delivered to mothers that are maintained on methadone are at risk for neonatal abstinence syndrome. Psychosocial support is provided to pregnant women in methadone maintenance program to impact the outcome of the infants. The percentage of infants requiring pharmacotherapy would be expected to be reduced by the addition of psychosocial intervention to methadone maintenance program.
Secondary Outcomes
- Gestational age at which the infants were delivered.(Gestational age at delivery.)
- Percentage of infants that are small for gestational age.(Gestional period.)
- Anthropometric measurements at birth(Measurements at birth.)
Investigators
Dr. Henry Akinbi
Associate Professor
Children's Hospital Medical Center, Cincinnati